Trials / Completed
CompletedNCT00407004
Elimination of Albumin-Bound Substances by MARS and Prometheus
Effect of Extracorporeal Liver Support by MARS and Prometheus on Albumin-Bound Substances in Acute-on-Chronic Liver Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (planned)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial compares the efficacy of two artificial liver support systems, MARS (Molecular Adsorbents Recirculating System) and Prometheus (FPSA, Fractionated Plasma Separation and Adsorption), in removing albumin-bound substances such as bilirubin, bile acids, and cytokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MARS (Molecular Adsorbents Recirculating System) | |
| DEVICE | Prometheus (FPSA, Fractionated Plasma Separation and Adsorption) |
Timeline
- Start date
- 2003-03-01
- Completion
- 2004-04-01
- First posted
- 2006-12-04
- Last updated
- 2006-12-04
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00407004. Inclusion in this directory is not an endorsement.